Piperazin-2-one → [2-(3-Oxopiperazin-1-yl)pyrimidin-5-yl]boronic acid

HRID 626936

Reaktionsgleichung

Reaktionsgleichung von HRID 626936
Cl[C:2]1[N:7]=[CH:6][C:5]([B:8]([OH:10])[OH:9])=[CH:4][N:3]=1.[NH:11]1[CH2:16][CH2:15][NH:14][CH2:13][C:12]1=[O:17]>O1CCOCC1>[O:17]=[C:12]1[NH:11][CH2:16][CH2:15][N:14]([C:2]2[N:7]=[CH:6][C:5]([B:8]([OH:10])[OH:9])=[CH:4][N:3]=2)[CH2:13]1

Komponenten

4

Edukt 2

HCID 231360Piperazin-2-oneHCID 21747362(2-Chloropyrimidin-5-yl)boronic acid

Produkt 1

HCID 89923662[2-(3-Oxopiperazin-1-yl)pyrimidin-5-yl]boronic acidAusbeute 50,3 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 312751,4-DioxaneLösungsmittel

Reaktionsbedingungen

Temperatur
100 °C

Versuchsvorschrift

(2-Chloropyrimidin-5-yl)boronic acid (1.0 g, 6.32 mmol) and piperazin-2-one (1.6 g, 16.0 mmol) were suspended in 1,4-dioxane (10 mL) and the mixture was heated at 100° C. under microwave irradiation for 45 minutes. The supernatant liquid was decanted from the suspension and the residue was triturated with methanol and diethyl ether. The resultant solids were filtered off and dried under vacuum to afford the title compound (706 mg, 30%) as a pale pink solid. Method B HPLC-MS: MH+ m/z 223, RT 0.25 minutes.

Aufarbeitung

  1. customThe supernatant liquid was decanted from the suspension
  2. customthe residue was triturated with methanol and diethyl ether
  3. filtrationThe resultant solids were filtered off
  4. customdried under vacuum

Quellen und Nachweise

ORD-Eintrag
ord-b52fb167cd004ee7938c204d46be5842
Quelldatensatz
uspto-grants-2016_04
Patentnummer
US09309243B2

Verknüpfte Notizen

Wird geladen…